Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and enkephalin, ala(2)-mephe(4)-gly(5)-

2-chloro-n(6)cyclopentyladenosine has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Trials
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-)
2520432,7271374

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McGuirk, SR; Pardee, AL; Pritchett, CE; Will, MJ1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and enkephalin, ala(2)-mephe(4)-gly(5)-

ArticleYear
The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake.
    Brain research, 2010, Jan-08, Volume: 1306

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Catheterization; Central Nervous System Agents; Dietary Fats; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Locomotion; Male; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Opioid, mu; Xanthines

2010